Zoetis Q1 FY26: where the revenue came from and where it went
The whole income statement of Zoetis for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 7, 2026
Revenue$2.26B
+3% year over year
Gross profit$1.62B
72% margin
Operating profit$0.74B
33% margin
Net profit$0.60B
27% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.26 | 100% | +3% |
| Livestock | 0.72 | 32% | |
| Dermatology | 0.35 | 15% | |
| Other revenue | 0.35 | 15% | |
| Anti infective products | 0.24 | 11% | |
| Pain sedation | 0.20 | 9% | |
| Other pharmaceuticals | 0.16 | 7% | |
| Swine | 0.12 | 6% | |
| Poultry | 0.12 | 5% | |
| Cost of revenue | −0.64 | 28% | |
| Gross profit | 1.62 | 72% margin | +0pp |
| SG&A | −0.59 | 26% | +0pp |
| Other | −0.30 | 13% | +0pp |
| Operating profit | 0.74 | 33% margin | −2pp |
| Other income, net | 0.02 | ||
| Tax | −0.16 | ||
| Net profit | 0.60 | 27% margin | −1pp |
98 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest